The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.20
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.30 (25.00%)
Open: 1.35
High: 1.35
Low: 1.35
Prev. Close: 1.35
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

20 Jun 2013 07:00

RNS Number : 4194H
Image Scan Holdings PLC
20 June 2013
 

Image Scan Holdings plc

Interim report 2013

 

 

20 June 2013

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

(AIM: IGE)

 

INTERIM RESULTS

FOR THE SIX MONTHS ENDED 31 MARCH 2013

 

Image Scan, the AIM-listed specialist supplier of real-time 3D and 2D x-ray screening systems to the security and industrial inspection markets, today announces its interim results for the six months ended 31 March 2013.

 

Financial summary:

·; Revenue of £1,072,000 (2012: £1,760,000)

·; Gross profit margin of 42% (2012: 37%)

·; Normal overheads of £715,000 (2012: £653,000)

·; Exceptional costs of £137,000 (2012: £nil)

·; Loss after taxation of £390,000 (2012: Profit £6,000)

·; Period end bank balance of £138,000 (2012: £122,000)

 

Operational highlights:

·; H1 revenue evenly balanced across both our core sectors

·; FlatScan sales continue to underpin security revenue

·; Sales of standard industrial systems to both new and existing customers

 

Post period end events:

·; Orders since the period end exceed £1.5m including:

o Repeat sales of SVXi, small vehicle x-ray inspection systems

o Multiple unit FlatScan-TPXi sale into the Middle East

o Sales of MDXi, industrial inspection systems to a new European customer

·; Total new orders for year to date of £2.3m (2012: £2.1m) having opened with £0.4m (2012: £2.1m) giving cumulative orders in current financial year of £2.7million

·; Ian Johnson to step down as non-executive director after over 11 years of service

 

Brian Emslie, Chairman of Image Scan, commented: "Having become profitable within the last 18 months, the loss reported in the interim results is particularly disappointing. This has occurred partly due to the flow of orders during the year being unevenly phased, with orders intake during the last three months of £1.5m being double that of the previous six. In addition an exceptional loss of £112,000 on the latter stages of the nuclear contract has been realised within the period. In the light of the first half trading performance and the repositioning of the Company towards standard product sales where costs can be better controlled, the Board has revisited the level of resourcing required and has restructured the business to streamline operations. This incurred a further exceptional charge of £25,000 in the period, but has reduced ongoing overheads by around 20%, at which level the Board is confident that the Company should be able to achieve profitability on a sustainable basis. However, the loss in the period coupled with the need to build for stock has made cash flow management challenging. The Board is actively looking at ways to provide further working capital to properly develop the business and to fund new product development. I would like to take this opportunity to thank Ian Johnson, who is standing down from the Board as of today, for over 11 years of invaluable service to the Company."

 

 

Enquiries:

 

Image Scan Holdings plc Tel: +44 (0) 1509 817 400

Brian Emslie, Chairman

Louise George, CEO

ir@ish.co.uk

 

Cantor Fitzgerald Europe (Nominated Adviser) Tel: +44 (0) 207 894 7000

Tom Sheldon / Rick Thompson

Paul Jewell/Richard Redmayne

Chairman’s statement

Introduction

I am pleased to present the Company's interim results for the six months ended 31 March 2013.

 

Financial results

Revenue for the six months at £1,072,000 (2012: £1,760,000) was down across both our core sectors mainly due to starting the year with a much lower opening order book of £400,000 (2012: £2.3million). The margin strengthened to 42% (2012: 37%) due to the sales mix being predominantly repeat builds of standard systems.

 

Administrative expenses on normal activities were up to £715,000 (2012: £653,000) which reflects increases across most areas of expenditure. In addition, there were two exceptional charges incurred:

·; An anticipated loss of £112,000 on the latter stages of the nuclear contract

·; Restructuring costs of £25,000 to reduce ongoing operating costs by 20%

 

The resultant loss after tax was £390,000 (2012: profit £6,000) and the loss per share was 0.5p (2012: profit per share of 0.01p).

 

The cash position as at the end of the period was £138,000 (2012: £122,000). The Company has an agreed £100,000 overdraft facility with the Royal Bank of Scotland. The current overdrawn bank balance of £56,000 reflects relatively high inventory levels. This investment has been necessitated by the need to respond swiftly to prospective contracts and has involved stock build of the critical and longer lead time components used in the FlatScan product range. This has given rise to a temporary increase in inventory of £200,000 since the start of the financial year

 

Overview

Security revenue in the period was £546,000 (2012: £1,120,000). The comparable period last year included £570,000 relating to the sale of the SVXi, small vehicle x-ray inspection system, which did not reoccur in the same period this year. However, revenue from other security products was comparable.

 

Industrial revenue of £526,000 (2012: £640,000) included the sale of an MDXi systems to an existing customer and MDXi systems to a new customer in the US.

 

Whilst the nuclear contract is expected to be marginally profitable overall, there is an anticipated loss of £112,000 on the latter stages. Up to the milestones within the period to March 2012, the contract was reportedly operating in line with the original budgeted costs and therefore the profit on those phases was recorded at that time. However, over the last year the completion of the software development has absorbed excess costs to a point that an exceptional loss of £112,000 has been recognised within the interim results. In addition to the actual cost, the Company is bearing the opportunity cost of having key development resources absorbed by this contract to the detriment of other critical product developments for the business. In the light of this experience, the Company will shift its focus primarily onto the production and sale of standard equipment, ideally from stock, where costs can be better controlled and margins improved, compared to large one-off projects.

 

Outlook

The Company has total confirmed orders of £2.7m having started the year with an opening order book of £0.4m (2012: £2.3m) and secured new orders in the year to date of £2.3m (2012: £2.1m). Of this £1.1m was recognised as revenue in the first half and of the remaining £1.6m, £1.2m should be deliverable prior to the financial year end. This rate of order intake is 14% ahead compared to the same period last year and comprises over 70% security sales.

 

Capitalising on the significant investment into product development last year, the Company has recently secured a repeat order for the SVXi, a mobile x-ray screening system targeted at customs and border control in South East Asia. Also since the period end the Company has sold a number of AXIS-64 and AXIS-3D baggage screening systems into the Middle East and Africa, and secured its first sale of the FlatScan-TPXi system into Germany and a multiple unit sale into the Middle East.

 

Recent industrial contract wins include the sale of MDXi x-ray inspection systems to a new customer in Europe. Meanwhile there are strong prospects of repeat sales from existing industrial clients.

 

In view of these results and the repositioning of the Company towards standard product sales, the Board has revisited the level of overheads and has restructured the business accordingly to reflect the future resource requirement. It is anticipated that the ongoing annual costs saving will be around 20%, the benefit of which should flow through in full in the last quarter.

 

As of today Ian Johnson will be standing down as non executive director having served on the Board of Image Scan since 2001. As a leading adviser to the security sector, Mr Johnson has provided invaluable support to the Company in identifying reputable partners and establishing reliable sales channels, particularly in the Middle East and the UK. His contribution over the past 11 years has been much appreciated by the rest of the Board.

 

 Given the underlying level of standard equipment sales in recent years, the Board anticipates that going forward the Company can achieve profitability on a sustainable basis, and that this will provide a platform for future growth. However, the Board is mindful of the challenges faced in managing the cash flow and is therefore considering ways of introducing further funding to meet the working capital requirements to operate and develop the business.

 

Brian Emslie

Chairman

20 June 2013

 

 

Consolidated income statement
for the six months ended 31 March 2013

Six months ended

Six months ended

Year ended

31 March 2013

31 March 2012

30 September 2012

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Revenue

1,072

1,760

4,302

Cost of sales

(619)

(1,102)

(2,647)

Gross profit

453

658

1,655

Administrative expenses

- Normal activities

(715)

(653)

(1,624)

- Losses on nuclear contract

(112)

-

-

- Restructuring costs

(25)

-

-

Operating profit/(loss)

(399)

5

31

Finance revenue

-

1

1

Profit/(loss) before taxation

(399)

6

32

Taxation

10

-

76

Profit/(loss) for the period

(389)

6

108

 

Pence

Pence

Pence

Earnings per share

Basic and diluted earnings/(loss) per share

(0.50)

0.01

0.14

 

 

Consolidated statement of changes in equity
for the six months ended 31 March 2013

Six months to

Six months to

Year to

31 March 2013

31 March 2012

30 September 2012

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Opening equity shareholders' funds

977

907

907

Share-based payments

-

-

(2)

Profit /(loss) attributable to equity shareholders

(390)

6

72

587

913

977

 

 

Consolidated balance sheet
as at 31 March 2013

 

As at

As at

As at

31 March 2013

31 March 2012

30 September 2012

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Non-current assets

Plant and equipment

31

47

39

Intangible assets

-

-

-

31

47

39

Current assets

Inventories

650

696

413

Trade and other receivables

240

437

1,122

Cash and cash equivalents

138

122

74

Current tax asset

-

-

75

1,028

1,255

1,684

Total assets

1,059

1,302

1,723

Current liabilities

Trade and other payables

426

390

700

Non-current liabilities

Provisions for liabilities and charges

46

34

46

Total liabilities

472

424

746

Net assets

587

878

977

Equity

Share capital

763

763

763

Share premium account

7,501

7,501

7,501

Retained earnings

(7,677)

(7,386)

(7,287)

Equity shareholders' funds

587

878

977

This interim financial information was approved by the Board of Directors on 20 June 2013.

 

 

Brian S Emslie

Chairman

 

Consolidated cash flow statement
for the six months ended 31 March 2013

Six months to

Six months to

Year to

31 March 2013

31 March 2012

30 September 2012

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Cash flows from operating activities

Operating profit/(loss)

(400)

5

31

Adjustments for:

Depreciation

11

16

34

Increase in inventories

(237)

(381)

(97)

Decrease/(increase) in trade and other receivables

548

130

(555)

(Decrease)/increase in trade and other payables

60

(604)

(283)

Share-based payment charge

-

-

(3)

Corporation tax recovered

85

29

30

Net cash (outflow)/inflow from operating activities

67

(805)

(843)

Cash flows from investing activities

Interest received

-

1

1

Purchase of property, plant and equipment

(3)

(19)

(29)

Proceeds on disposal of property, plant and equipment

-

-

-

Net cash used in investing activities

(3)

(18)

(28)

Cash flows from financing activities

Issue of ordinary share capital

-

-

-

Net cash generated from financing activities

-

-

-

Net (decrease)/increase in cash and cash equivalents

64

(823)

(871)

Cash and cash equivalents at beginning of period

74

945

945

Cash and cash equivalents at end of period

138

122

74

 

Notes to the unaudited interim financial statements

for the six months ended 31 March 2013

1 Basis of preparation

The interim financial information for the six months ended 31 March 2013 has been prepared under International Financial Reporting Standards ('IFRS') as adopted by the EU in accordance with International Accounting Standard 34 'Interim Financial Reporting'. The interim financial statements have been prepared in accordance with the Company's accounting policies under IFRS and the historical cost convention. The interim financial statements are neither audited nor reviewed and do not constitute statutory accounts as defined by Section 434 of the Companies Act 2006. The comparatives for the financial year ended 30 September 2012 are not the Company's full statutory accounts for the year. The Auditors' report on those accounts was unqualified and did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies.

 

2 Going concern

The interim financial information has been prepared on a going concern basis, which assumes that the Company will have adequate resources to continue in operational existence for the foreseeable future.

 

3 Earnings per share ('EPS')

Basic earnings per ordinary share is based on the profit on ordinary activities after taxation of £6,000 and on 76,267,932 ordinary shares in issue throughout the period.

 

IAS 33 requires presentation of diluted EPS when a company could be called upon to issue shares that would decrease net profit or increase net loss per share. Earnings or loss per share would not be affected by the exercise of out-of-the-money options since it is inappropriate to assume that option holders would act irrationally. Accordingly as there are no other diluting future share issues, diluted EPS equals basic EPS.

 

4 IFRS 2 'Share-based payments'

Operating expenses includes a charge of £nil (2012: £nil) after valuation of the Company's employee share option schemes in accordance with IFRS 2. Under this standard, the fair value of the options at the grant date is spread over the vesting period. These items have been added back in the consolidated statement of changes in equity.

 

5 Additional copies

Further copies of the interim report 2013 are available on the Company's website, www.ish.co.uk, and from the Company's registered office, 16-18 Hayhill Industrial Estate, Sileby Road, Barrow-upon-Soar, Leicestershire LE12 8LD.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR KMGMVFLNGFZM
Date   Source Headline
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding
18th Jan 20238:52 amRNSPosting of annual report and notice of AGM
17th Jan 20233:23 pmRNSImage Scan makes first sale of new product
23rd Dec 202211:54 amRNSDirector/PDMR Shareholding
14th Dec 20224:14 pmRNSAppointment of Director
13th Dec 20224:25 pmRNSHolding(s) in Company
13th Dec 20227:00 amRNSFinal Results
9th Dec 20227:00 amRNSNotice of Results
6th Oct 20227:00 amRNSTrading Update
1st Aug 20224:10 pmRNSHolding(s) in Company
25th May 20227:00 amRNSBoard Changes
27th Apr 20227:00 amRNSInterim Results
3rd Mar 20227:00 amRNSNew Industrial Customer
22nd Feb 20223:03 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Statement
20th Jan 202211:53 amRNSPosting of Accounts & AGM Notice
12th Jan 20227:00 amRNSLaunch of new portable X-ray system
10th Dec 20219:05 amRNSInvestor Presentation
7th Dec 202110:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
7th Dec 20217:00 amRNSFinal Results
10th Nov 20211:16 pmRNSAppointed global distributor for Serstech AB
10th Nov 20217:00 amRNSPortable x-ray sale to US Federal Agency
3rd Nov 20217:00 amRNSPre-Close Trading Update
27th Oct 20219:32 amRNSDirector Declaration
13th Sep 20217:00 amRNSTrading Update – New Orders
17th Jun 20217:00 amRNSFirst portable X-Ray sale to Australia
28th Apr 202110:03 amRNSInterim Report - Replacement
28th Apr 20217:00 amRNSNew order
28th Apr 20217:00 amRNSInterim Report
23rd Feb 202111:18 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.